Aims To quantify usage of COX‐2 inhibitors compared with nonselective NSAIDs and to
determine their impact (including financial) on the co‐prescription of antipeptic ulcer (anti …

Abstract In 1985 the Committee for Safety of Medicines warned that cotrimoxazole was likely
to cause adverse effects, particularly bone marrow suppression and death in patients over …

Objectives: To examine the effect of the debate on the safety of non‐steroidal anti‐
inflammatory drugs (NSAIDs) on decision making by Australian general practitioners and …

Our Editorial Committee presents a panel discussion on conflicts of interest in order to
formulate a reflection on the issue. The panel defines “conflict of interest” both in general …

Background It is unclear what impact Helicobacter pylori infection has had on the
management of dyspepsia in primary care and to what extent published guidelines on H …

Objetivo Envejecimiento y medicalización de la sociedad suponen un crecimiento del gasto
farmacéutico. Interesa desarrollar estudios que evalúen este gasto para dar soporte a …

What is already known about this subject• Prior to the worldwide withdrawal of rofecoxib in
2004, due to cardiovascular toxicity with its use, selective COX‐2 inhibitors had been shown …

Background: Both in the European and Polish guidelines the highest priority for preventive
cardiology was given to patients with established cardiovascular disease. The Cracovian …

Background: Helicobacter pylori eradication regimens have failure rates under 10%,
however little information is available on the effect of treatment success in reducing the …